Your-Doctor Multiple Choice Questions (MCQ)

Quiz Categories Click to expand

Category: Urology--->Prostate Cancer
Page: 1

Question 1#Print Question

Which of the following is TRUE regarding adenocarcinoma of the prostate?

a. Is the fourth commonest cause of male cancer death in the UK
b. Is more common in men than breast carcinoma is in women
c. Is more common in the transition zone than in the peripheral zone
d. Has never been recorded in patients with congenital 5α-reductase deficiency
e. The critical feature in the pathological diagnosis is preservation of basal cell layer


Question 2#Print Question

Which of the following is NOT a recognised side effect of LHRH agonists in the treatment of carcinoma of the prostate?

a. Osteoporosis
b. An initial drop in plasma testosterone
c. Gynaecomastia
d. Hot flushes
e. Erectile dysfunction


Question 3#Print Question

Which of the following is TRUE regarding brachytherapy monotherapy for prostate cancer? 

a. Should be considered in the management of intermediate- and high-risk localised prostate cancer
b. HDR uses palladium103 as the radioactive source
c. Low dose rate (permanent seed implantation) (LDR) and high dose rate (HDR) temporary implantation represent the two types of brachytherapy
d. There is no limitation in relation to prostate size
e. A ‘PSA bounce’ is less common after brachytherapy than after external beam radiotherapy


Question 4#Print Question

Which finding is TRUE in the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4), comparing radical prostatectomy versus watchful waiting in the management of early prostate cancer after up to 10 years follow-up?

a. Radical prostatectomy reduces prostate cancer-specific mortality, overall mortality, the risks of metastasis and local progression compared with watchful waiting
b. Radical prostatectomy has no benefit in terms of overall survival
c. Radical prostatectomy has no benefit in terms of disease specific survival
d. Radical prostatectomy has no benefit in terms of reducing prostate cancerspecific mortality, overall mortality, the risks of metastasis or local progression
e. With longer follow up any difference in terms of cancer specific survival between the radical prostatectomy and watchful waiting is likely to decrease


Question 5#Print Question

Which of the following drugs have shown efficacy in the treatment of ‘hot flushes’ following hormonal treatment for advanced prostate cancer?

a. Diethylstilbestrol
b. 5α-reductase inhibitors
c. Medroxyprogesterone acetate
d. Tamsulosin
e. Clonidine




Category: Urology--->Prostate Cancer
Page: 1 of 2